| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |